Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Christopher F. Bell's publication output changed over time?
ScholarIQpublication output · 2002–2023
Output grew100% over the shown period — from 1 works in 2002 to 2 in 2023.
1
1
1
1
1
2
1
1
1
2
2002200520072012201420152016202020222023
What are the most-cited papers on Christopher F. Bell?
ScholarIQmost cited works
The burden of Duchenne muscular dystrophy
Erik Landfeldt, Peter Lindgren, Christopher F. Bell, Claude Schmitt, Michela Guglieri, Volker Straub, Hanns Lochmüller, K. Bushby
Neurology. 2014230 CitationsOPEN ACCESS
Quantifying the burden of caregiving in Duchenne muscular dystrophy
Erik Landfeldt, Peter Lindgren, Christopher F. Bell, Michela Guglieri, Volker Straub, Hanns Lochmüller, K. Bushby
Journal of Neurology. 2016143 CitationsOPEN ACCESS
Health‐related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross‐sectional study
Erik Landfeldt, Peter Lindgren, Christopher F. Bell, Michela Guglieri, Volker Straub, Hanns Lochmüller, K. Bushby
Developmental Medicine & Child Neurology. 2015127 CitationsOPEN ACCESS
Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data
Christopher F. Bell, Jonathan Graham, Stephanie Earnshaw, MerriKay Oleen-Burkey, Jane Castelli‐Haley, Kenneth P. Johnson
S40961437. 2007106 CitationsOPEN ACCESS
Compliance to Care Guidelines for Duchenne Muscular Dystrophy
Erik Landfeldt, Peter Lindgren, Christopher F. Bell, Claude Schmitt, Michela Guglieri, Volker Straub, Hanns Lochmüller, K. Bushby
Journal of Neuromuscular Diseases. 201593 CitationsOPEN ACCESS
Related on ScholarIQ
Family Health International 360
Institution
The burden of Duchenne muscular dystrophy
Paper
Quantifying the burden of caregiving in Duchenne muscular dystrophy
Paper
Health‐related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross‐sectional study
Paper
Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data
Paper
Compliance to Care Guidelines for Duchenne Muscular Dystrophy
Paper